Año: 2018
Journal Impact Factor (JIF): 14.1960
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| ONCOLOGY | SCIE | 9/230 | Q1 | T1 | D1 |
Año: 2018
Journal Citation Indicator (JCI): 2,780
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| ONCOLOGY | 9/302 | Q1 | T1 | D1 | 97,19 |
Año:
2018
CiteScore:
20,400
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Hematology | 2/122 | Q1 | T1 | D1 |
| Oncology | 9/323 | Q1 | T1 | D1 |
SJR año:
2018
Factor de Impacto:
6,047
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Hematology | 3/142 | Q1 | T1 | D1 |
| Medicine (miscellaneous) | 33/2805 | Q1 | T1 | D1 |
| Oncology | 8/401 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| Adaptaimmune | - |
| Advenchen | - |
| Amcure | - |
| Amgen | - |
| Amgen Dompe | - |
| AROG Bayer | - |
| AstraZeneca | - |
| Bayer | - |
| Blueprint Medicines | - |
| Boehringer Ingelheim | - |
| Bristol-Myers Squibb | - |
| CoBioRes | - |
| Cristal Therapeutics | - |
| Daichii Sankyo Pharma | - |
| Daiichi Sankyo Pharma | - |
| Eisai | - |
| Eli Lilly | - |
| Epizyme | - |
| Epizyme Inc. | - |
| EuroSarc | - |
| Exelixis | - |
| Genzyme | - |
| GlaxoSmithKline | - |
| Incyte | - |
| Ipsen | - |
| Janssen-Cilag | - |
| Lilly | - |
| Loxo Oncology | - |
| Medpace | - |
| Menarini | - |
| Merck Sharp Dohme | - |
| Milestone | - |
| Nanobiotix | - |
| Nektar | - |
| Novartis | - |
| Novartis Oncology | - |
| Pfizer | - |
| PharmaMar | - |
| Philogen | - |
| Piqur Therapeutics | - |
| Plexxikon | - |
| Roche | - |
| Sixth Element Capital | - |
| Swedish Orphan Biovitrium | - |
| # | Autor |
|---|---|
| 1 | Casali, PG |
| 2 | Abecassis, N |
| 3 | Bauer, S |
| 4 | Biagini, R |
| 5 | Bielack, S |
| 6 | Bonvalot, S |
| 7 | Boukovinas, I |
| 8 | Bovee, JVMG |
| 9 | Brodowicz, T |
| 10 | Broto, JM |
| 11 | Buonadonna, A |
| 12 | De Alava, E |
| 13 | Tos, APD |
| 14 | Del Muro, XG |
| 15 | Dileo, P |
| 16 | Eriksson, M |
| 17 | Fedenko, A |
| 18 | Ferraresi, V |
| 19 | Ferrari, A |
| 20 | Ferrari, S |
| 21 | Frezza, AM |
| 22 | Gasperoni, S |
| 23 | Gelderblom, H |
| 24 | Gil, T |
| 25 | Grignani, G |
| 26 | Gronchi, A |
| 27 | Haas, RL |
| 28 | Hannu, A |
| 29 | Hassan, B |
| 30 | Hohenberger, P |
| 31 | Issels, R |
| 32 | Joensuu, H |
| 33 | Jones, RL |
| 34 | Judson, I |
| 35 | Jutte, P |
| 36 | Kaal, S |
| 37 | Kasper, B |
| 38 | Kopeckova, K |
| 39 | Krakorova, DA |
| 40 | Le Cesne, A |
| 41 | Lugowska, I |
| 42 | Merimsky, O |
| 43 | Montemurro, M |
| 44 | Pantaleo, MA |
| 45 | Piana, R |
| 46 | Picci, P |
| 47 | Piperno-Neumann, S |
| 48 | Pousa, AL |
| 49 | Reichardt, P |
| 50 | Robinson, MH |
| 51 | Rutkowski, P |
| 52 | Safwat, AA |
| 53 | Schoffski, P |
| 54 | Sleijfer, S |
| 55 | Stacchiotti, S |
| 56 | Hall, KS |
| 57 | Unk, M |
| 58 | Van Coevorden, F |
| 59 | Van der Graaf, W |
| 60 | Whelan, J |
| 61 | Wardelmann, E |
| 62 | Zaikova, O |
| 63 | Blay, JY |